Skip to main content




You(r) Biocom

Biocom recognizes your team's impact on California life science

Biocom Advocacy

Learn how H.R. 3 Would Slash Life-Saving R&D in California


Biocom Member Spotlight Series

For nearly 25 years, our 1,200 members have been instrumental in shaping transformative programming and powerful advocacy that help researchers, investors and advocates alike in our mission to accelerate California’s largest, most innovative network of life science clusters in the world. Through the Biocom Member Spotlight series, we sit down with some of California’s life science leaders to learn more about the journeys they’ve endured to achieve life-changing solutions for our industry.

Read full interviews here


Biocom offices are located in the heart of several California life science clusters, as well as areas key to our many active public policy initiatives. Headquartered in San Diego, Biocom’s additional locations are in Los Angeles, the Bay Area, Washington, D.C., and Tokyo.

Learn More

Biocom Ribbon Cutting


Take advantage of 30+ RFP-vetted life science-related contracts.


You(r) Biocom
Learn More

Recognizing your team’s impact on California life science

2019 Catalyst Awards
Learn More

View the 2019 Catalyst Awards Winners

Our Process
Learn More

See how our members guide our Savings Portfolio

Events & Networking
Learn More

250+ annual life science events

“I have had the opportunity to give presentations to VCs and Pharma Venture Funds at several Venture Day events. These experiences have been very helpful with respect to meeting investors from outside the San Diego area and also for valuable feedback. This is an important Biocom program!”
Michael J. Newman, CEO, Decoy Biosystems
“The LSYL (Life Science Young Leaders) series is a terrific idea. It’s just easier to make meaningful connections among contemporaries and this series is a great platform for that. I look forward to the next one.”
Brendan McCarthy, Attorney, Gunderson Dettmer Stough Villeneuve Franklin & Hachigan
“I was impressed with Biocom’s DeviceFest & Digital Health Conference on August 29th, 2018. The conference had a balance view of content and discussion time with industry experts, which allowed us to have deeper introductory meetings, which will lead to deeper relationships with experts from all over North America. Great job by the planning committee and the management of Biocom.”
Dipak Shah, Board Member, Obsidio Therapeutics, Inc.


Sign up for Biocom’s monthly newsletter to get all the latest life science news sent directly to your inbox.